Opposite effects of a GABAB antagonist in two models of epileptic seizures in developing rats

Brain Research Bulletin

Volumn 71, Issue 1-3, 2006, Pages 160-166

  Mareš, Pavel ^a   Šlamberová, Romana ^a,b  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

GABAB; Ontogeny; Rat; Seizures; Spike and wave rhythm

Indexed keywords

ACTION POTENTIALS; AGING; ANIMALS; ANIMALS, NEWBORN; CEREBRAL CORTEX; CONVULSANTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; ELECTROENCEPHALOGRAPHY; EPILEPSY; EPILEPSY, ABSENCE; GABA AGONISTS; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; NEURAL INHIBITION; RATS; RATS, WISTAR; RECEPTORS, GABA-B; SYNAPTIC TRANSMISSION; TREATMENT OUTCOME;

EID: 33751013016     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2006.08.013     Document Type: Article

References (49)

1. Avanzini G., de Curtis M., Marescaux C., Panzica F., Spreafico R., and Vergnes M. Role of the thalamic reticular nucleus in the generation of rhythmic thalamo-cortical activities subserving spike and waves. J. Neural Transm. Suppl. 35 (1992) 85-95
2. Berkovic S.F. Childhood absence epilepsy and juvenile absence epilepsy. In: Wyllie E. (Ed). The Treatment of Epilepsy: Principles and Practice (1993), Lea & Fibiger, Philadelphia 547-551
3. Bernášková K., Šlamberová R., and Mareš P. GABA uptake blocker NNC 711 exhibits marked anticonvulsant action in two cortical epileptic models in immature rats. Epilepsia 40 (1999) 1184-1189
4. B receptor antagonists: from synthesis to therapeutic application. Trends Pharmacol. Sci. 14 (1993) 391-394
5. B receptors: structure and function. Pharmacol. Rev. 54 (2002) 217-264
6. B receptor site distribution in the rat central nervous system. Neuroscience 20 (1987) 365-383
7. Browning R.A., and Nelson D.K. Modification of electroshock and pentylenetetrazol seizure patterns in rats after precollicular transections. Exp. Neurol. 93 (1986) 546-556
8. B receptor antagonist SCH 50911 in rats undergoing ethanol withdrawal syndrome. Eur. J. Pharmacol. 445 (2002) 195-199
9. B binding sites in rat central nervous system: a quantitative autoradiographic study. Neuroscience 34 (1990) 341-357
10. B receptors in excitation and inhibition of thalamocortical cells. Trends Neurosci. 14 (1991) 16-21
11. Deisz R.A., Billard J.M., and Ziegelgänsberger W. Presynaptic and postsynaptic GABA receptors of neocortical neurons of the rat in vitro: differences in pharmacology and ionic mechanisms. Synapse 25 (1997) 62-72
12. B-receptor splice variants GB1a and GB1b in rat brain: developmental regulation, cellular distribution and extrasynaptic localization. Eur. J. Neurosci. 11 (1999) 761-768
13. B inhibition in rat somatosensory cortex. J. Neurophysiol. 70 (1993) 448-452
14. Hejnová L., Ihnatovych I., Novotný J., Kubová H., Mareš P., and Svoboda P. Modulation of adenylyl cyclase activity by baclofen in the developing rat brain: difference between cortex, thalamus and hippocampus. Neurosci. Lett. 330 (2002) 9-12
15. B receptor antagonist, in the lethargic mouse, γ-hydroxybutyrate, and pentylenetetrazole models. J. Pharmacol. Exp. Ther. 274 (1995) 1399-1403
16. Howe J.R., Sutor B., and Ziegelgänsberger W. Baclofen reduces postsynaptic potentials of rat cortical neurones by an action other than its hyperpolarizing action. J. Physiol. (London) 384 (1987) 539-569
17. B receptor blocker CGP 35348. Neuroscience 47 (1992) 63-68
18. Kubová H., Haugvicová R., and Mareš P. Moderate anticonvulsant action of baclofen does not change during development. Biol. Neonate 69 (1996) 405-412
19. Kubová H., Mareš P., and Vorlíček J. Stable anticonvulsant action of benzodiazepines during development in rats. J. Pharm. Pharmacol. 45 (1993) 807-810
20. B-receptor blockade in the freely moving rat. Epilepsia 46 (2005) 203-216
21. Liu Z., Vergnes M., Depaulis A., and Marescaux C. Evidence for a critical role of GABAergic transmission within the thalamus in the genesis and control of absence seizures in the rat. Brain Res. 545 (1991) 1-7
22. Löscher W., and Schmidt D. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res. 2 (1988) 145-181
23. Macdonald R.L. Cellular actions of antiepileptic drugs. In: Eadie M.J., and Vajda F.J.E. (Eds). Antiepileptic Drugs. Pharmacoloy and Terapeutics (1999), Springer Verlag, Berlin 123-150
24. Malitschek B., Ruegg D., Held J., Kaupmann K., Bittiger H., Frostl W., Bettler B., and Kuhn R. Developmental changes of agonist affinity at GABA R1 receptor variants in rat brain. Mol. Cell Neurosci. 12 (1998) 56-64
25. Manning J.P., Richards D.A., Leresche N., Crunelli V., and Bowery N.G. Cortical-area specific block of genetically determined absence seizures by ethosuximide. Neuroscience 123 (2004) 5-9
26. Marcus E.M. Experimental models of petit mal epilepsy. In: Purpura D.P., Penry J.K., Tower D., Woodbury D.M., and Walter R. (Eds). Experimental Models of Epilepsy (1972), Raven Press, New York 113-146
27. Mareš P. Ontogeny of ethosuximide action against two seizure models in rats is different. Life Sci. (Pharmacol. Lett.) 63 (1998) PL 51-57
28. Mareš P. Anticonvulsant action of three neurosteroids against cortical epileptic afterdischarges in immature rats. Brain Res. Bull. 68 (2005) 179-184
29. Mareš P., Haugvicová R., and Kubová H. Unequal development of thresholds for various phenomena induced by cortical stimulation in rats. Epilepsy Res. 49 (2002) 35-43
30. Mareš P., and Zouhar A. Do we possess adequate models of childhood epilepsies?. Physiol. Bohemoslov. 37 (1988) 1-9
31. B receptor antagonists: potential new anti-absence drugs. J. Neural Transm. Suppl. 35 (1992) 179-188
32. Meeren H.K., Pijn J.P., Van Luijtelaar E.L., Coenen A.M., and Lopes da Silva F.H. Cortical focus drives widespread corticothalamic networks during spontaneous absence seizures in rats. J. Neurosci. 22 (2002) 1480-1495
33. Polášek R., Kubová H., Šlamberová R., Mareš P., and Vorlíček J. Suppression of cortical epileptic afterdischarges in developing rats by anticonvulsants increasing GABAergic inhibition. Epilepsy Res. 25 (1996) 177-184
34. B receptor protein in somatosensory cortex and thalamus of adult rats and during postnatal development. Brain Res. Bull. 5 (2000) 397-405
35. Puigcerver A., vanLuijtelaar E.L.J.M., Drinkenburg W.H.I.M., and Coenen A.L.M. Effects of the GABA(B) antagonist CGP 35348 on sleep-wake states, behaviour, and spike-wave discharges in old rats. Brain Res. Bull. 40 (1996) 157-162
36. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizures. Electroenceph. Clin. Neurophysiol. 32 (1972) 281-294
37. Schickerová R., Mareš P., and Trojan S. Correlation between electrocorticographic and motor phenomena induced by metrazol during ontogenesis in rats. Exp. Neurol. 84 (1984) 153-164
38. B mediated mechanisms in experimental generalized absence seizures. Eur. J. Pharmacol. 213 (1992) 343-349
39. Snead III O.C. Pharmacological models of generalized absence seizures in rodents. J. Neural Transm. Suppl. 35 (1992) 7-19
40. B receptors to thalamic neuronal activity during spontaneous absence seizures in rats. J. Neurosci. 21 (2001) 1378-1384
41. Steriade M. Sleep, epilepsy and thalamic reticular inhibitory neurons. Trends Neurosci. 28 (2005) 317-324
42. Steriade M., and Deschenes M. The thalamus as a neuronal oscillator. Brain Res. Rev. 8 (1984) 1-62
43. B receptors in convulsant-induced epileptiform activity in rat neocortex in vitro. Eur. J. Neurosci. 10 (1998) 3417-3427
44. Timofeev I., and Steriade M. Neocortical seizures: initiation, development and cessation. Neuroscience 123 (2004) 299-336
45. Tolmacheva E., van Luijtelaar G., Chepurnov S.A., Kaminskij Yu., and Mareš P. Cortical and limbic excitability in rats with absence epilepsy. Epilepsy Res. 62 (2004) 189-198
46. B binding in rat brain. Neuroscience 62 (1994) 601-613
47. Velíšek L., Velíšková J., Ptachewich Z., Ortíz J., Shinnar S., and Moshé S.L. Age-dependent effects of GABA agents on flurothyl seizures. Epilepsia 36 (1995) 636-643
48. Vergnes M., Boehrer A., Simler S., Bernasconi R., and Marescaux C. Opposite effects of GABAB receptor antagonists on absences and convulsive seizures. Eur. J. Pharmacol. 332 (1997) 245-255
49. Vergnes M., Marescaux C., Micheletti G., Depaulis A., Rumbach L., and Warter J.M. Enhancement of spike-and-wave discharges by GABA-mimetic drugs in rats with spontaneous petit mal-like epilepsy. Neurosci. Lett. 44 (1984) 91-94